Negative effects of transfused blood components after hepatectomy for metastatic colorectal cancer

American Surgeon

Volumn 79, Issue 1, 2013, Pages 35-39

  Cannon, Robert M ^a   Brown, Russell E ^a   St Hill, Charles R ^a   Dunki Jacobs, Eric ^a   Ii, Robert C G Martin ^a   Mcmasters, Kelly M ^a   Scoggins, Charles R ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FRESH FROZEN PLASMA;

ADULT; ADVERSE OUTCOME; ARTICLE; BLOOD COMPONENT THERAPY; CANCER SURVIVAL; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE FREE SURVIVAL; ERYTHROCYTE TRANSFUSION; HUMAN; LIVER RESECTION; MAJOR CLINICAL STUDY; METASTASIS; OVERALL SURVIVAL; SURGICAL RISK; THERAPY EFFECT; THROMBOCYTE TRANSFUSION; AGED; COLORECTAL TUMOR; EVALUATION; LIVER TUMOR; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; RETROSPECTIVE STUDY; STATISTICAL MODEL; SURVIVAL; TREATMENT OUTCOME;

AGED; BLOOD COMPONENT TRANSFUSION; COLORECTAL NEOPLASMS; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; LOGISTIC MODELS; MIDDLE AGED; MULTIVARIATE ANALYSIS; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

MLCS; MLOWN;

EID: 84875077228     PISSN: 00031348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Opelz G, Terasaki PI. Dominant effect of transfusions on kidney graft survival. Transplantation 1980;29:153-8.
2. Burrows L, Tartter P. Effect of blood transfusions on colonic malignancy recurrent rate. Lancet 1982;2:662.
3. Ghio M, Contini P, Mazzei C, et al. In vitro immunosuppressive activity of soluble HLA class I and Fas ligand molecules: do they play a role in autologous blood transfusion? Transfusion 2001;41:988-96.
4. Vamvakas EC, Blajchman MA. Transfusion-related immunomodulation (TRIM): an update. Blood Rev 2007;21:327-48.
5. Marsh J, Donnan PT, Hamer-Hodges DW. Association between transfusion with plasma and the recurrence of colorectal carcinoma. Br J Surg 1990;77:623-6.
6. Parrott NR, Lennard TW, Taylor RM, et al. Effect of perioperative blood transfusion on recurrence of colorectal cancer. Br J Surg 1986;73:970-3.
7. Foster RS Jr., Costanza MC, Foster JC, et al. Adverse relationship between blood transfusions and survival after colectomy for colon cancer. Cancer 1985;55:1195-201.
8. Kooby DA, Stockman J, Ben-Porat L, et al. Influence of transfusions on perioperative and long-term outcome in patients following hepatic resection for colorectal metastases. Ann Surg 2003;237:860-9.
9. Puppo F, Ghio M, Contini P, et al. Fas, Fas ligand, and transfusion immunomodulation. Transfusion 2001;41:416-8.
10. Moore PK, Benson D, Kehler M, et al. The plasma fraction of stored erythrocytes augments pancreatic cancer metastasis in male versus female mice. J Surg Res 2010;164:23-7.
11. Vamvakas EC. Possible mechanisms of allogeneic blood transfusion- associated postoperative infection. Transfus Med Rev 2002;16:144-60.
12. Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg 2009;250:187-96.
13. Rosen CB, Nagorney DM, Taswell HF, et al. Perioperative blood transfusion and determinants of survival after liver resection for metastatic colorectal carcinoma. Ann Surg 1992;216:493-504.
14. Younes RN, Rogatko A, Brennan MF. The influence of intraoperative hypotension and perioperative blood transfusion on disease-free survival in patients with complete resection of colorectal liver metastases. Ann Surg 1991;214:107-13.
15. Stephenson KR, Steinberg SM, Hughes KS, et al. Perioperative blood transfusions are associated with decreased time to recurrence and decreased survival after resection of colorectal liver metastases. Ann Surg 1988;208:679-87.
16. Peters WR, Fry RD, Fleshman JW, Kodner IJ. Multiple blood transfusions reduce the recurrence rate of Crohn's disease. Dis Colon Rectum 1989;32:749-53.
17. Gantt CL. Red blood cells for cancer patients. Lancet 1981; 2:363.
18. Vamvakas EC, Blajchman MA. Deleterious clinical effects of transfusion-associated immunomodulation: fact or fiction? Blood 2001;97:1180-95.
19. House MG, Ito H, Gonen M, et al. Survival after hepatic resection for metastatic colorectal cancer: trends in outcomes for 1,600 patients during two decades at a single institution. JAm Coll Surg 2010;210:744-5.
20. Brouquet A, Mortenson MM, Vauthey JN, et al. Surgical strategies for synchronous colorectal liver metastases in 156 consecutive patients: classic, combined or reverse strategy? J Am Coll Surg 2010;210:934-41.
21. Aloia TA, Vauthey JN, Loyer EM, et al. Solitary colorectal liver metastasis: resection determines outcome. Arch Surg 2006; 141:460-6.
22. Minagawa M, Makuuchi M, Torzilli G, et al. Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results. Ann Surg 2000; 231:487-99.
23. Tomlinson JS, Jarnagin WR, Dematteo RP, et al. Actual 10-year survival after resection of colorectal liver metastases defines cure. J Clin Oncol 2007;25:4575-80.
24. Jamnicki M, Kocian R, van der Linden P, et al. Acute normovolemic hemodilution: physiology, limitations, and clinical use. J Cardiothorac Vasc Anesth 2003;17:747-54.
25. Monk TG, Goodnough LT, Brecher ME, et al. A prospective randomized comparison of three blood conservation strategies for radical prostatectomy. Anesthesiology 1999;91:24-33.
26. Segal JB, Blasco-Colmenares E, Norris EJ, Guallar E. Preoperative acute normovolemic hemodilution: a meta-analysis. Transfusion 2004;44:632-44.
27. Martin RC,Wellhausen SR, Moehle DA, et al. Evaluation of intraoperative autotransfusion filtration for hepatectomy and pancreatectomy. Ann Surg Oncol 2005;12:1017-24.
28. Carless PA, Henry DA, Carson JL, et al. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev 2010;10:CD002042.